Editorial: IBD cost evolution - transitioning from compensating lost productivity to escalating medication expenses

Ashkan Rezazadeh Ardabili*, Adriaan A Van Bodegraven

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

Abstract

LINKED CONTENT This article is linked to Everhov et al paper. To view this article, visit
Original languageEnglish
Pages (from-to)832-833
Number of pages2
JournalAlimentary Pharmacology & Therapeutics
Volume58
Issue number8
DOIs
Publication statusPublished - 1 Oct 2023

Cite this